v3.26.1
SCHEDULE OF BASIC AND DILUTED NET LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Total net income (loss) per share attributed to shareholders:        
Net income (loss) attributable to Quantum X Labs Inc shareholders $ 2,485 $ (11,658) $ 1,880 $ (15,326)
Interest expenses on convertible loans 17 43
Adjusted net income (loss) $ 2,502 $ (11,658) $ 1,923 $ (15,326)
Weighted average shares [1] 14,292,085 7,235,599 12,903,662 6,330,104
Warrants and converted loans 5,782,540,000 6,140,200,000
Dilutive potential common shares 5,782,540 6,140,200
Adjusted weighted average shares [1] 20,074,625 7,235,599 19,043,862 6,330,104
Basic earnings (loss) per share attributable to Quantum X Labs Inc shareholders $ 0.17 $ (1.61) $ 0.15 $ (2.42)
Diluted earnings (loss) per share attributable to Quantum X Labs Inc shareholders $ 0.12 $ (1.61) $ 0.10 $ (2.42)
[1] Share and per share data in these financial statements for periods preceding the Reverse Stock Split have been retrospectively adjusted to reflect a number of shares that is equivalent to the number of shares of the Company post the Reverse Stock Split (see note 10.G).